Related Experiment Videos

First report of chronic meningitis caused by Trichosporon beigelii

I Surmont1, B Vergauwen, L Marcelis

  • 1Department of Microbiology, St. Rafael University Hospital, Leuven, Belgium.

Insights

A rare case of chronic meningitis caused by Trichosporon beigelii in a leukemia patient is detailed. Diagnosis was aided by cross-reactivity in a cryptococcal antigen test, highlighting challenges in fungal meningitis identification.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Fungal meningitis is a serious complication, particularly in immunocompromised individuals.
  • Trichosporon beigelii is an opportunistic pathogen that can cause invasive infections.
  • Acute lymphocytic leukemia (ALL) patients undergoing chemotherapy are at high risk for opportunistic infections due to neutropenia.

Observation:

  • A 15-year-old boy with ALL developed chronic meningitis after cytostatic treatment and itraconazole prophylaxis.
  • Cerebrospinal fluid (CSF) cultures confirmed Trichosporon beigelii as the causative agent during a neutropenic episode.
  • Clinical improvement was observed with a combination antifungal therapy, but CSF pleocytosis persisted.

Findings:

  • The study identified Trichosporon beigelii as the cause of chronic meningitis in an immunocompromised pediatric patient.
  • A cryptococcal antigen latex test showed cross-reactivity with Trichosporon beigelii, aiding in diagnosis of CSF and serum samples.
  • Combination therapy including amphotericin B, flucytosine, and high-dose fluconazole was initiated for treatment.

Implications:

  • This case highlights the importance of considering rare fungal pathogens like Trichosporon beigelii in immunocompromised patients with meningitis.
  • The diagnostic utility of cryptococcal antigen latex test cross-reactivity in identifying Trichosporon infections is demonstrated.
  • Effective management of Trichosporon meningitis requires a multi-faceted approach involving prompt diagnosis and aggressive antifungal therapy.

Related Concept Videos